Bavarian Nordic — Juni 2023
-
Tak @YPE, så må det være det man sigter efter... har skrevet og spurgt Rolf alligevel. Det er ikke sikkert at han svarer...
-
når i spørge ham, så hør lige til denne fra deres q1 ppt. Expanding portfolio with acquired travel vaccines
• 6,100 m2 laboratory and GMP manufacturing
facility in San Diego, US
• Focused on research and development of
infectious disease pipeline candidates -
CDC ACIP holder møde i disse dage bl.a. om RSV-vaccine. På mødet i går deltog både GSK og Pfeizer, hvor der bl.a. meget andet diskuteres boosters, follow-up, prissætning etc. Her er de samlede noter fra Alexander Tin https://twitter.com/Alexander_Tin/status/1671644648912089090 og her kan du finde hans udvalgte noter på twittter https://twitter.com/Alexander_Tin/status/1671644648912089090
-
Svar fra Rolf i forlængelse af 13:19: "Vi forventer Ph 3 RSV data i løbet af sommeren"
-
Worktrader..Det var mig der havde lavet en fejl. Bliver rettet i ny video.
-
Forøvrigt en stor tak.
-
..most welcome. Apropos, 167,239 Chikungunya Cases Confirmed in Paraguay
https://www.precisionvaccinations.com/2023/06/22/167239-chikungunya-cases-confirmed-paraguay -
..kontra 'From 2006–2021, 4,590 chikungunya cases in travelers were confirmed in the U.S.' - godt nok noget af en stigning...og kan måske forklare de varierende tal, vi har set på det potentielle marked...
-
...og sundhedsstyrelsen i DK udvider målgruppen for mpox vaccination, og følger - naturligvis - ECDC's opdaterede retningslinier, https://www.sst.dk/da/nyheder/2023/Flere-anbefales-vaccination-og-faerre-anbefales-selvisolation-ved-mpox
-
..'slikkelap'..hmm, kan godt se, jeg er ved at blive gammel
-
I morgen fra CDC 23/6 - Vedr. Chicago og de øgede mpox-tilfælde i år blandt allerede vaccinerede. Der er kommet mere frem og mere skal undersøges, bl.a. temperatur og "handling" af vacciner: https://www.cdc.gov/mmwr/volumes/72/wr/mm7225a6.htm
-
CDC 23/6 - Covid-19 data til og med Dec 2022 "Reinfections accounted for 24.8% of hospitalizations and 20.2% of deaths in adults aged 18–49 years during the BQ.1/BQ.1.1 period" https://www.cdc.gov/mmwr/volumes/72/wr/mm7225a3.htm?s_cid=mm7225a3_w Altså gruppen 18-49 årige er mere "udsatte" end ældre personer ved de nyere Omicron-varianter.
-
STAT+ (ref 14:14) ACIP & RSV: GSK og Pfizer får IKKE den anbefaling de håbede på vedr. vaccine for +60-årige. https://www.statnews.com/2023/06/21/cdc-advisory-panel-recommends-seniors-may-get-rsv-vaccine/ Vi får se om CDC følger ACIP-anbefalingen, der sikkert vil medføre lavere salg...
-
(fort.) "Earlier in the day the committee looked set to vote on a stronger recommendation, one that would have urged all people 65 and older to get vaccinated against respiratory syncytial virus. But that recommendation was watered down after a long discussion during which several members of the committee expressed serious concerns about the decisions they were being asked to make based on the data the companies had provided."
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind